Open AccessLong-term follow-up of asymptomatic Brugada patients with inducible ventricular fibrillation under hydroquinidine
Author(s) -
Abdeslam Bouzeman,
Sarah Traullé,
A. Messali,
Fabrice Extramiana,
Isabelle Denjoy,
Kumar Narayanan,
Éloi Marijon,
J.-S. Hermida,
Antoine Leenhardt
Publication year - 2013
Publication title -
ep europace
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 102
eISSN - 1532-2092
pISSN - 1099-5129
DOI - 10.1093/europace/eut279
Subject(s) - medicine , asymptomatic , brugada syndrome , implantable cardioverter defibrillator , ventricular fibrillation , cardiology , confidence interval
To evaluate the long-term efficacy and safety of an electrophysiologically guided therapy, based on a strategy of treatment using hydroquinidine (HQ) among asymptomatic Brugada patients with inducible ventricular fibrillation (VF).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom